Direction
Buy
Sell
Types
LMT Order
Price
QTY
Amount
--
MDT Medtronic
82.580+0.740+0.90%
Close
01/27 16:00 ET
82.750+0.170+0.21%
Post Mkt Price 01/27 19:55 ET
High
83.170
Open
82.180
Turnover
400.62M
Low
80.810
Pre Close
81.840
Volume
4.86M
Post-Market
5D
1D
1W
1M
1Q
1Y
Price Forecast
News
Comment
Medtronic Plc (NYSE:MDT) Receives Average Rating of "Hold" From Analysts
Medtronic plc (NYSE:MDT – Get Rating) has received an average rating of "Hold" from the twenty-four research firms that are currently covering the company, MarketBeat.com reports. One analyst has r
Tivic Health Systems (NASDAQ:TIVC) Vs. Medtronic (NYSE:MDT) Head-To-Head Contrast
Medtronic (NYSE:MDT – Get Rating) and Tivic Health Systems (NASDAQ:TIVC – Get Rating) are both medical companies, but which is the better business? We will compare the two companies based on the stre
The Use of Artificial Intelligence in Medical Devices and Drug Development
Forum Financial Management LP Boosts Stake in Medtronic Plc (NYSE:MDT)
Forum Financial Management LP raised its holdings in Medtronic plc (NYSE:MDT – Get Rating) by 3.1% during the third quarter, according to its most recent disclosure with the Securities & Exchange Co
Medtronic (MDT) Outpaces Stock Market Gains: What You Should Know
Medtronic PLC Stock Outperforms Market On Strong Trading Day
This article was automatically generated by MarketWatch using technology from Automated Insights. Shares of Medtronic PLC (MDT) inched 0.90% higher to $82.58 Friday, on what proved to be an all-aroun
Orchestra BioMed Begins Trading on Nasdaq With Cash Runway Into 2026
Medtronic (NYSE:MDT) PT Lowered to $95.00 at Mizuho
Medtronic (NYSE:MDT – Get Rating) had its target price lowered by Mizuho from $100.00 to $95.00 in a report published on Tuesday morning, The Fly reports. The brokerage currently has a buy rating on
Medtronic PLC Stock Rises Thursday, Still Underperforms Market
This article was automatically generated by MarketWatch using technology from Automated Insights. Shares of Medtronic PLC (MDT) inched 0.79% higher to $81.84 Thursday, on what proved to be an all-aro
Global Hernia Mesh Devices Market Report to 2030 - Featuring Medtronic, Johnson & Johnson, Atrium and Life Cell Among Others - ResearchAndMarkets.com
DUBLIN--(BUSINESS WIRE)--The "Hernia Mesh Devices Market Size, Share & Trends Analysis Report by Hernia Type (Inguinal Hernia, Incisional Hernia, Femoral Hernia), by Mesh Type (Biologic Mesh, Syntheti
Company Overview
More
Medtronic Plc is a medical technology company, which engages in the development, manufacture, distribution, and sale of device-based medical therapies and services. It operates through the following segments: Cardiovascular Porrtfolio, Neuroscience Portfolio, Medical Surgical Portfolio, and Diabetes Operating Unit. The Cardiovascular Portfolio segment includes products for the diagnosis, treatment, and management of cardiac rhythm disorders and cardiovascular disease. The Neuroscience Portfolio is made up of cranial and spinal technologies, specialty therapies, and neuromodulation divisions. The Medical Surgical Portfolio is comprised of surgical innovations and respiratory, gastrointestinal, and renal divisions. The Diabetes Group segment offers insulin pumps, continuous glucose monitoring systems, and insulin pump consumables. The company was founded in 1949 and is headquartered in Dublin, Ireland.
CEO： Mr. Geoffrey S. Martha
Market： NYSE
Listing Date： 11/21/1977
Paper Trade
More
Hot List
TradeSearchNews
SymbolLatest price%Chg
Loading...
Watchlist
No Stock Yet